Erratum to "Public health and rare diseases: Oxymoron no more" [Prev Chronic Dis., 13, (2016), E05] DOI:10.5888/pcd13.150491;Public health and rare diseases: Oxymoron no more

Preventing Chronic Disease

Volumn 13, Issue 1, 2016, Pages

  Valdez, Rodolfo ^a   Ouyang, Lijing ^a   Bolen, Julie ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; PUBLIC HEALTH; RARE DISEASES;

DELIVERY OF HEALTH CARE; HEALTH PRIORITIES; HUMANS; PUBLIC HEALTH; RARE DISEASES;

EID: 84959017341     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd13.150491e     Document Type: Erratum

References (16)

1. Institute of Medicine. The future of public health. IOM Publication no. 88-02. National Academy Press: Washington (DC); 1988.
2. Centers for Disease Control and Prevention (CDC). Ten great public health achievements - United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011;60(19):619-23.
3. Norheim OF, Jha P, Admasu K, Godal T, Hum RJ, Kruk ME, et al. Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health. Lancet 2015; 385(9964):239-52.
4. de Vrueh R, Baekelandt ERF, de Haan JMH. Priority medicines for Europe and the world: "a public health approach to innovation." WHO Background Paper 6.19. Rare Diseases; 2013. http://www.who.int/medicines/areas/priority_medicines/ BP6_19Rare.pdf. Accessed December 16, 2015.
5. Institute of Medicine (US). Rare diseases and orphan products: accelerating research and development 2010. Washington (DC): National Academies Press; 2010.
6. Rofail D, Maguire L, Kissner M, Colligs A, Abetz-Webb L. A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers. Neurol Ther 2013;2(1-2):1-12.
7. Ouyang L, Grosse SD, Riley C, Bolen J, Bishop E, Raspa M, Bailey DB Jr. A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability. Res Dev Disabil 2014; 35(7):1518-27.
8. Grosse SD, Boyle CA, Kenneson A, Khoury MJ, Wilfond BS. From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Pediatrics 2006;117(3):923-9.
9. Therrell BL, Adams J. Newborn screening in North America. J Inherit Metab Dis 2007;30(4):447-65.
10. Wolff T, Witkop CT, Miller T, Syed SB; US Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med 2009; 150(9):632-9.
11. Williams J, Mai CT, Mulinare J, Isenburg J, Flood TJ, Ethen M, et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification - United States, 1995-2011. MMWR Morb Mortal Wkly Rep 2015;64(1):1-5.
12. MacKenzie T, Gifford AH, Sabadosa KA, Quinton HB, Knapp EA, Goss CH, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med 2014; 161(4):233-41.
13. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. The International TSD Data Collection Network. Tay-Sachs disease - carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. JAMA 1993;270(19):2307-15.
14. Lew RM, Burnett L, Proos AL, Barlow-Stewart K, Delatycki MB, Bankier A, et al. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience. J Paediatr Child Health 2015;51(3):271-9.
15. Aymé S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet 2008; 371(9629):2048-51.
16. Dunkle M, Pines W, Saltonstall PL. Advocacy groups and their role in rare diseases research. In: Posada de la Paz M, Groft SC, editors. Rare Diseases Epidemiology. Adv Exp Med Biol 2010;686:515-25. New York (NY): Springer Science; 2010.